For Medicare Advantage inpatient admissions, submit prior authorization requests for CAR-T cell therapy drugs to NovoLogix
Before you begin administering CAR-T cell therapy drugs for Medicare Plus BlueSM or BCN AdvantageSM members in an inpatient setting, you must do the following:
For the inpatient admission, follow the steps in the "Submit an inpatient authorization" section of the e-referral User Guide (PDF).
If you've been submitting the prior authorization request for CAR-T cell therapy drugs through the e-referral system, this is a change. This change is effective immediately.
If you have questions, email us at MASRX@bcbsm.com.
As a reminder:
NovoLogix offers real-time status checks and immediate approvals for certain medications. If you have access to Provider Secured Services, you already have access to enter authorization requests through NovoLogix.
If you need to request access to Provider Secured Services, complete the Provider Secured Access Application (PDF) form and fax it to the number on the form.
List of requirements
For a list of requirements related to drugs covered under the medical benefit, please see the Medical Drug and Step Therapy Prior Authorization List for Medicare Plus Blue PPO and BCN Advantage members. (PDF)
Posted: May 2021
Lines of business: Blue Cross Blue Shield of Michigan and Blue Care Network